Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-0.02x - -0x - - - - 85.99L
32.5x6.07x0.92x8.11x25.42x25.71x0.05% 5.38TCr
20.55x3.97x-2.4x6.33x13.85x16.08x1.55% 5.47TCr
-41.97x54.37x0.7x13.33x-39.1x-43.04x-.--% 2.32TCr
-18.41x1.13x2.77x4.42x-7.74x-6.52x-.--% 2.33TCr
25.05x2.45x1.83x4.93x13x15.55x-.--% 2TCr
24.1x2.74x-1.14x4.73x15.4x17.36x-.--% 1.73TCr
45.12x11.57x0.4x18.26x47.03x43.14x0.08% 1.5TCr
-524.03x21.47x10.68x36.52x-1516.27x-449.86x-.--% 1.54TCr
17.45x4.96x1.21x5.07x11.8x13x-.--% 1.4TCr
-74.05x28.4x1.69x7.94x-67.23x-55.2x-.--% 1.24TCr
-12.35x-83.82x6.12x90.83x-13.98x-13.61x-.--% 1.07TCr
-11.88x139.71x0.58x3078.64x-14.3x-11.69x-.--% 1.05TCr
-22.24x23.86x-0x20.62x-26.02x-20.96x-.--% 1.01TCr
3162.91x7.72x-30.99x13.53x82.58x283.28x-.--% 1.1TCr
-17.77x8.84x3.8x114x-15.94x-14.49x - 884.33Cr
-31.67x8.7x-0.57x - -29.25x-28.29x-.--% 855.89Cr
-6.52x - -0.13x - -6.68x-6.14x-.--% 801.41Cr
12.02x5.92x0.03x7.84x12.55x13.26x-.--% 864.87Cr
-8.82x - -0.07x - - - - 784.99Cr
Average 128.50x 14.59x -0.23x 214.69x -84.16x -12.36x 0.1% 1.67TCr
Weighted average by Cap. 84.35x 12.43x -0.05x 119.99x -66.66x -8.36x 0.28%
Bio Therapeutic Drugs